Cashu
LENSAR Advances Eye Care with Innovative Surgical Technologies and Commitment to Quality
8 months ago
Stocks
Health Care
lnsr
LENSAR
NASDAQ: LNSR
+0.09 (+0.91%)
9.95
USD
At close at Nov 18, 21:43 UTC
Overview
Loading chart...
Key Stats
Market Cap
117.68M
Dividend Yield
0.00%
P/E Ratio
-2.28
EPS
-2.73
Revenue
53.49M
Avg. Volume
75.88K
About
What does LNSR do?
LENSAR, based in Orlando, Florida, develops femtosecond laser technology for cataract surgery and went public on September 21, 2020. Its product line includes the LENSAR Laser System and ALLY System, enhancing surgical outcomes.
Sector
💻 Health Care
IPO
CEO
Employees
140
Headquarters
Florida, USA
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.